Navigation Links
BioMarin Initiates Phase 3b Study to Evaluate the Effects of Kuvan on Neurophychiatric Symptoms in Subjects with PKU
Date:8/17/2010

jects twelve to 17 years of age and the Adult ADHD Self-Report Scale (ASRS) in subjects ages 18 and above.  The Clinical Global Impression of Improvement (CGI-I) scale will be assessed to determine improvement in global impression of behavior, symptoms and functioning relative to treatment as the primary efficacy endpoint for global function.

About BioMarinBioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Other product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in clinical development for the treatment of MPS IVA and PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking StatementThis press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the expectations about the timing, conduct and impact of the clinical trial
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
2. BioMarin Announces FDA Approval for Kuvan
3. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
6. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
7. BioMarin Acquires Huxley Pharmaceuticals, Inc.
8. BioMarin to Present at the Oppenheimer Healthcare Conference
9. BioMarin Announces Third Quarter 2009 Financial Results
10. BioMarin to Acquire LEAD Therapeutics
11. BioMarin to Present at the Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal ... quarter financial results. Net sales for ... billion, an increase of 0.5% compared with the ... growth in local currencies and a 7.0% decline ...
(Date:7/29/2015)... July 29, 2015  Efforts to improve working capital ... pharmaceutical firms in North America ... that an effective working capital management will ease the ... cliffs. Big pharma companies expect to invest in optimizing ... - http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis from ...
(Date:7/28/2015)... , July 28, 2015 Codman Neuro*, part ... introduced a new platform of embolic coils for the ... system designed to improve microcatheter stability and provide an ... was made here at the Society of NeuroInterventional Surgery ... family of framing, filling and finishing coils used during ...
Breaking Medicine Technology:Henry Schein Reports Record Second Quarter Results 2Henry Schein Reports Record Second Quarter Results 3Henry Schein Reports Record Second Quarter Results 4Henry Schein Reports Record Second Quarter Results 5Henry Schein Reports Record Second Quarter Results 6Henry Schein Reports Record Second Quarter Results 7Henry Schein Reports Record Second Quarter Results 8Henry Schein Reports Record Second Quarter Results 9Henry Schein Reports Record Second Quarter Results 10Henry Schein Reports Record Second Quarter Results 11Henry Schein Reports Record Second Quarter Results 12Henry Schein Reports Record Second Quarter Results 13Henry Schein Reports Record Second Quarter Results 14Henry Schein Reports Record Second Quarter Results 15Henry Schein Reports Record Second Quarter Results 16Henry Schein Reports Record Second Quarter Results 17Henry Schein Reports Record Second Quarter Results 18Henry Schein Reports Record Second Quarter Results 19Henry Schein Reports Record Second Quarter Results 20Henry Schein Reports Record Second Quarter Results 21Henry Schein Reports Record Second Quarter Results 22Henry Schein Reports Record Second Quarter Results 23Henry Schein Reports Record Second Quarter Results 24Henry Schein Reports Record Second Quarter Results 25Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces the ... general contact information, website, types of plans administered, years in business, and credentials of ... have at least one plan with Employee Fiduciary. A search can be done by ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... the Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Inc ., a global provider of life insurance, annuities, employee benefits and asset ... North Carolina inclusive sporting event taking place in Charlotte, North Carolina on ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, M.D., ... to be chosen by the manufacturer to offer and perform Kybella™ ... way to treat and eliminate double chin fat,” Dr. Callahan explained. “Previously this ...
(Date:7/29/2015)... ... 2015 , ... Nature’s Artisan, a new holistic oral care company, has released ... was founded by Tina Yarandi, who came up with the idea for the product ... was amazed when she learned about the incredible dental benefits of xylitol, but was ...
Breaking Medicine News(10 mins):Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... the worlds of academia, research, government and industry ... state-of-the-art// communications technology can make healthcare accessible and ... field that encompasses a range of health services ... citizen-oriented information provision and virtual healthcare teams. ...
... :The alarming number of NTD's or neural tube defects in ... has recommended that most bread// in Ireland should include folic ... supplements in women. ,This would indeed help offsetting ... low on folic acid, and do not take adequate folic ...
... California in Los Angeles, study the diet patterns in 52 ... found// that the normal people generally ate more fruits and ... was published in the Journal of the American Dietetic Association ... low dietary fibre and fruit intake, plays a role in ...
... related to drinking have more than doubled in Britain in just ... by the Office for National Statistics (ONS) revealed has revealed that ... 2004. The statistics also showed that the alcohol related deaths were ... increasing in recent years. ,It was explained that in ...
... farmworker families in North Carolina and Virginia found evidence ... researchers to call for pesticide safety training for workers’ ... researchers from Wake Forest University School of Medicine report ... of pesticide exposure than had been found in similar ...
... and has put the draft regulation out for consultation//. ... wanted to know about the people's views ahead of the ... it would be nice if the smoking ban extended to ... the plan would be expensive and is very complicated. ...
Cached Medicine News:Health News:Delhi to Host E-health Global Meet Next Month 2Health News:Better Weight Management Can be Achieved By Increased Intake Of Fibre & Fruits 2Health News:Research Documents Children’s Exposure to Pesticide 2
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
... The DYONICS POWERMAX Shaver Handpiece has ... than the standard Smith & Nephew handpiece ... for easier handling and reduced hand fatigue. ... as the suction lever are all co-located ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
... brought arthroscopic shaver systems to a new ... of the Powershaver SL. Just the latest ... leader in surgical endoscopy, the Powershaver SL ... highly specialized field of arthroscopic surgery. ,Whether ...
Medicine Products: